Clinical Trials Browser

NIH × Lymphoma, B-Cell × Ipilimumab × Clear all

NCT01729806 2018-04-11

Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma

Phase 1 Completed

Lymphoma, B-Cell